| 2026-08-17 | Press release | OmniAb Raises 2026 Financial Guidance |
| 2026-08-17 | Press release | OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company |
| 2026-08-06 | Press release | OmniAb to Report Second Quarter 2026 Financial Results on August 6 |
| 2026-08-06 | Press release | Press release · Q2 2026 · Aug 2026 |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-06 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-13 | Press release | OmniAb Names Amechi Nwachuku Chief Operating Officer |
| 2026-07-13 | 8-K | Form 8-K, Item 5.02 |
| 2026-06-18 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-07 | Press release | OmniAb Reports First Quarter 2026 Financial Results and Business Highlights |
| 2026-05-07 | Press release | OmniAb to Report First Quarter 2026 Financial Results on May 7 |
| 2026-05-07 | Deck | Presentation of Q1 2026 |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-29 | Proxy | Definitive proxy statement |
| Transcript | Q1 FY26 earnings call transcript |
| 2026-03-08 | Press release | OmniAb to Participate at the Leerink Partners Global Healthcare Conference |
| 2026-03-04 | Press release | Press release · FY 2025 · Mar 2026 |
| 2026-03-04 | Press release | OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 |
| 2026-03-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-04 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-30 | 8-K | Form 8-K, Item 5.03 |
| 2025-12-15 | Press release | Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery |
| 2025-12-15 | Press release | OmniAb to Hold OmniUltra Virtual Investor Event on December 15 |
| 2025-11-19 | Deck | Investor presentation · Nov 2025 |
| 2025-11-17 | Press release | OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Comp |
| 2025-11-04 | Deck | Q3 2025 Financial Results & Business Update |
| 2025-11-04 | Press release | OmniAb to Report Third Quarter 2025 Financial Results on November 4 |
| 2025-11-04 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-04 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-16 | Press release | OmniAb to Participate in Three Investor Conferences in November |
| 2025-08-25 | Press release | OmniAb Announces $30 Million Private Placement |
| 2025-08-25 | 8-K | Form 8-K, Item 1.01 |
| 2025-08-06 | Deck | Q2 2025 Financial Results & Business Update |
| 2025-08-06 | Quarterly report | FORM 10-Q · Q2 2025 |
| 2025-08-06 | Press release | OmniAb to Report Second Quarter 2025 Financial Results on August 6 |
| 2025-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-06-18 | 8-K | Form 8-K, Item 5.07 |